Auricular neuromodulation

OTHER2 trials

Sponsors

Fondation Ophtalmologique Adolphe de Rothschild, Hôpital Européen Marseille

Conditions

Covid19Migraine DisordersSARS-CoV Infection

Unknown Phase

Impact of Auricular Vagus Nerve Neuromodulation on COVID-19 Positive Inpatients Outcome

TerminatedNCT04341415

Fondation Ophtalmologique Adolphe de RothschildCovid19, SARS-CoV Infection

Start: 2020-04-09End: 2021-01-15Updated: 2021-04-13

Treatment of Episodic Migraine With AURICular Neuromodulation

RecruitingNCT06623188

Hôpital Européen MarseilleMigraine Disorders

Start: 2025-05-20End: 2027-11-20Target: 106Updated: 2025-07-01

Related Papers

Auricular neuromodulation by low level laser therapy versus placebo laser therapy in prophylactic treatment of episodic migraine: a randomized controlled study protocol.

2025-10-14

Auricular Neuromodulation for Mass Vagus Nerve Stimulation: Insights From SOS COVID-19 a Multicentric, Randomized, Controlled, Double-Blind French Pilot Study

Frontiers in Physiology2021-08-0213 citations